On World Diabetes Day, we at Abarceo Pharma AB stand with the millions of people around the world living with type 1 diabetes – a chronic autoimmune disease with no apparent treatment. Abarceo pledges to bring a new, disease modifying, treatment to type -1 and type -2...
We are proud to present groundbreaking data at the 5th Swedish Diabetes Summit, revealing a novel approach to treating type 2 diabetes through VDAC1 oligomerization inhibitors. We share our exciting poster presented by our Principal Scientist Ruchi Jain and our...
Adam Bruce, CEO & Chair of Abarceo Pharma, presents at Investing in Life Science – From Seed To Success. About the event On September 12, 2024, BioStock and Vator Securities hosted the investment-focused event, Investing in Life Science: From Seed to...
BioStock’s Natasha Bank interviews Adam Bruce, CEO & Chair of Abarceo Pharma, at Investing in Life Science – From Seed To Success. About the event On September 12, 2024, BioStock and Vator Securities hosted the investment-focused event, Investing in Life...
Today ABARCEO PHARMA is celebrating the birthday of Sir Frederick Banting, who discovered insulin. It is also the World Diabetes Day, this year with the theme, “Breaking Barries, Bridging Gaps”Truly the spirit that we at Abarceo live and work by in the...
November 4–6 were spent at BIO-Europe® in Stockholm. It is an amazing event, bringing together not only the European but the global, this time 5500 strong, Biotech BD family. “I am grateful to the organizers for a great event making the 30th anniversary truly...
Recent Comments